IgE CONTENT OF COMMERCIAL INTRAVENOUS IgG PREPARATIONS
- 1 February 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 323 (8374) , 458
- https://doi.org/10.1016/s0140-6736(84)91797-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Frequency of Malignant Neoplasms in 248 Long-Term Methotrexate-Treated PsoriaticsDermatology, 1983
- Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancyCancer, 1982
- Characterization of Various Immunoglobulin Preparations for Intravenous ApplicationPublished by Wiley ,1982
- ACUTE MYELOMONOCYTIC LEUKAEMIA AFTER RAZOXANE THERAPYThe Lancet, 1981
- RAZOXANE IN THE TREATMENT OF PSORIASISBritish Journal of Dermatology, 1980
- Razoxane (ICRF 159) in the treatment of psoriasisBritish Journal of Dermatology, 1980
- Methotrexate in psoriasisJournal of the American Academy of Dermatology, 1980
- Is Methotrexate Therapy for Psoriasis Carcinogenic?Published by American Medical Association (AMA) ,1975
- Life-span carcinogenicity tests with 4-amino-N10-methylpteroylglutamic acid (methotrexate) in Swiss mice and Syrian golden hamstersToxicology and Applied Pharmacology, 1973
- A new and simple radioimmunoassay method for the determination of IgEImmunochemistry, 1972